Key result
Hospice and palliative care may benefit patients with end-stage heart failure who have refractory symptoms despite optimal medical therapy.
This review highlights the importance of hospice and palliative care for patients with end-stage heart failure experiencing refractory symptoms.
Supports palliative care consideration in refractory end-stage HF; leaves open need for randomized trials to guide adoption.
Heart failure, characterized by the inability of the ventricles to fill or eject blood, is a significant problem for patients and their families. This disease is characterized by periods of exacerbation and remission; patients must cope with the unpredictability and variability of symptoms. Classification systems for patients diagnosed with heart failure assist providers, patients, and families in understanding the chronic and progressive nature of heart disease. In the final stage, patients have refractory symptoms despite optimal medical therapy. At this stage, patients may benefit from hospice and palliative care. This article reviews essential points in the care of patients who are living with-and dying from-end-stage heart failure.
No takes yet. Share an insight, caveat, or question.
Hemani et al. (2008) conducted a review in End-stage heart failure. Hospice and palliative care was evaluated. Hospice and palliative care may benefit patients with end-stage heart failure who have refractory symptoms despite optimal medical therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: